AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - FEBRUARY 10, 2025 - The office building of AstraZeneca, a biopharmaceutical company, is seen in Shanghai, China, February 10, 2025.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - FEBRUARY 10, 2025 - The office building of AstraZeneca, a biopharmaceutical company, is seen in Shanghai, China, February 10, 2025.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - FEBRUARY 10, 2025 - The office building of AstraZeneca, a biopharmaceutical company, is seen in Shanghai, China, February 10, 2025.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - FEBRUARY 10, 2025 - The office building of AstraZeneca, a biopharmaceutical company, is seen in Shanghai, China, February 10, 2025.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - FEBRUARY 10, 2025 - The office building of AstraZeneca, a biopharmaceutical company, is seen in Shanghai, China, February 10, 2025.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - FEBRUARY 10, 2025 - The office building of AstraZeneca, a biopharmaceutical company, is seen in Shanghai, China, February 10, 2025.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - FEBRUARY 10, 2025 - The office building of AstraZeneca, a biopharmaceutical company, is seen in Shanghai, China, February 10, 2025.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - FEBRUARY 10, 2025 - The office building of AstraZeneca, a biopharmaceutical company, is seen in Shanghai, China, February 10, 2025.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

AstraZeneca Building in Shanghai

AstraZeneca Building in Shanghai

SHANGHAI, CHINA - MAY 23, 2024 - - The office building of biopharmaceutical company AstraZeneca is seen in Shanghai, China, May 23, 2024.

Biopharmaceutical

Biopharmaceutical

HEFEI, CHINA - OCTOBER 6, 2023 - Aerial photo taken by Anhui Zhifei Longkema Biopharmaceutical Co., LTD in Hefei, Anhui province, China, Oct 6, 2023.

Biopharmaceutical

Biopharmaceutical

HEFEI, CHINA - OCTOBER 6, 2023 - Aerial photo taken by Anhui Zhifei Longkema Biopharmaceutical Co., LTD in Hefei, Anhui province, China, Oct 6, 2023.

CHINA-SICHUAN-CHONGQING-LI QIANG-INSPECTION (CN)

CHINA-SICHUAN-CHONGQING-LI QIANG-INSPECTION (CN)

(231215) -- CHONGQING, Dec. 15, 2023 (Xinhua) -- Chinese Premier Li Qiang, also a member of the Standing Committee of the Political Bureau of the Communist Party of China Central Committee, visits Chengdu Tianfu International Bio-town, a biopharmaceutical enterprise, in Chengdu, southwest China's Sichuan Province, Dec. 13, 2023. Li made an inspection tour in southwest China's Sichuan Province and Chongqing Municipality from Wednesday to Friday. (Xinhua/Huang Jingwen)

China, Cuba sign agreements to boost biotechnology cooperation

STORY: China, Cuba sign agreements to boost biotechnology cooperation DATELINE: Sept. 9, 2023 LENGTH: 00:01:10 LOCATION: Havana CATEGORY: TECHNOLOGY SHOTLIST: 1. various of the meeting 2. various of the signing ceremony STORYLINE: The 12th Meeting of the Cuba-China Joint Working Group of Biotech Cooperation closed Thursday in the Cuban capital, Havana, with the signing of agreements between the two countries. The agreements include creating joint ventures, developing medicines for cancer treatment, creating a biopharmaceutical industrial park and other topics of common interest. Wu Hao, China's secretary general of the National Development and Reform Commission, said that the two countries will also sign a memorandum of understanding as soon as possible to enhance biotechnology collaboration. "China and Cuba complement each other in establishing a satisfactory base with huge potential for development," he said, adding that the two sister nations will continue to consolidate work results in yea

Initiative to strengthen cross-regional coordinated development of life, health industry launched in N China

STORY: Initiative to strengthen cross-regional coordinated development of life, health industry launched in N China DATELINE: Aug. 27, 2023 LENGTH: 00:01:18 LOCATION: LANGFANG, China CATEGORY: SOCIETY/HEALTH SHOTLIST: 1. various of the conference 2. SOUNDBITE (English): CARL-ALEXANDER SCHEEF, Head of Product Supply China, Bayer Pharmaceutical Division STORYLINE: An initiative to strengthen the coordinated development of life sciences and healthcare industry in China's Hebei Province and the national capital Beijing was launched Saturday. At a high-quality development forum for the biopharmaceutical industry held in Langfang, Hebei Province, the Beijing Daxing International Airport Economic Zone and the China Association for Vaccines (CAV), along with some enterprises in the industry, unveiled the initiative and called for more cooperations and better mechanisms. SOUNDBITE (English): CARL-ALEXANDER SCHEEF, Head of Product Supply China, Bayer Pharmaceutical Division "So we saw very good discussions and pro

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- Staff members work at a packing workshop of a pharmaceutical company in Wenshan City, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Zhang Haob

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- A farmer fertilizes a panax notoginseng field in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Jiang We

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- This photo shows wild panax notoginseng in Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- This aerial photo shows a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- Staff members work at a pharmaceutical company in Wenshan City, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Zhang Haobo)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- Farmers work at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/L

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- A farmer is pictured at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- A woman works at a packing workshop of a pharmaceutical company in Wenshan City, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Zhou Dixiao)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- People sort panax notoginseng products at a market in Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, Nov. 27, 2022. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Photo by Yang Denghong/Xinhua)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- Farmers fertilize a panax notoginseng field in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Honggu

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- Famers pose for a group photo at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. do

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- Farmers are pictured at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- This aerial photo shows a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- A farmer fertilizes a panax notoginseng field in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Jiang We

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- Famers pose for a group photo at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. do

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- Famers pose for a group photo at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. do

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- A farmer is pictured at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- This photo shows panax notoginseng fruits at a panax notoginseng cultivation base in Lianhuatang Town of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, Nov. 5, 2022. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- A farmer checks the growth of panax notoginseng in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Ho

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

CHINA-YUNNAN-WENSHAN-PANAX NOTOGINSENG CULTIVATION (CN)

(230601) -- WENSHAN, June 1, 2023 (Xinhua) -- A farmer fertilizes the panax notoginseng field in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023. The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Ho

French pharma giant Sanofi deepens vaccine cooperation with China's Shenzhen

STORY: French pharma giant Sanofi deepens vaccine cooperation with China's Shenzhen DATELINE: April 6, 2023 LENGTH: 0:02:19 LOCATION: SHENZHEN, China CATEGORY: ECONOMY/HEALTH SHOTLIST: 1. various of the signing ceremony 2. SOUNDBITE 1 (English): THOMAS TRIOMPHE, Executive vice president, Head of Vaccines, Sanofi 3. various of Pingshan district 4. SOUNDBITE 2 (English): THOMAS TRIOMPHE, Executive vice president, Head of Vaccines, Sanofi 5. SOUNDBITE 3 (English): THOMAS TRIOMPHE, Executive vice president, Head of Vaccines, Sanofi STORYLINE: French pharmaceutical giant Sanofi and Pingshan district government in China's Shenzhen on Tuesday signed a letter of intent on vaccine cooperation. The two sides agreed to accelerate the introduction of innovative vaccines to the Chinese market and promote innovative development of biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). SOUNDBITE 1 (English): THOMAS TRIOMPHE, Executive vice president, Head of Vaccines, Sanofi "It's a pleasur

Dominicans highlight effectiveness of vaccine from China's Sinovac

STORY: Dominicans highlight effectiveness of vaccine from China's Sinovac DATELINE: Feb. 4, 2023 LENGTH: 00:01:01 LOCATION: Santo Domingo CATEGORY: HEALTH SHOTLIST: 1. various of the Dominican Republic 2. SOUNDBITE 1 (Spanish): ARIS YVAN LORENZO, Legislator in Dominican Republic 3. SOUNDBITE 2 (Spanish): LORRAINE HERNANDEZ, Obstetrics physician in Dominican Republic 4. various of the Dominican Republic STORYLINE: Dominicans who have benefited from COVID-19 vaccines from the Chinese biopharmaceutical company Sinovac highlighted on Friday the help provided by China to face the pandemic. SOUNDBITE 1 (Spanish): ARIS YVAN LORENZO, Legislator in Dominican Republic "We Dominicans feel highly grateful to the Chinese people. At a time when the world was in the dark during the search for medicine to face a great challenge that was the COVID-19 pandemic, the Chinese people appeared and gave us peace of mind." SOUNDBITE 2 (Spanish): LORRAINE HERNANDEZ, Obstetrics physician in Dominican Republic "The vaccine that we

Yearender: Xinhua's top 10 world news events in 2022

Yearender: Xinhua's top 10 world news events in 2022

(221230) -- BEIJING, Dec. 30, 2022 (Xinhua) -- This photo taken on Aug. 31, 2022 shows the production line of COVID-19 vaccine under the Butantan Institute in the state of Sao Paulo, Brazil. Since June 2020, Chinese biopharmaceutical company Sinovac has carried out cooperation with the Butantan Institute to conduct a number of clinical studies, the most important of which is the Phase III clinical trial of the COVID-19 vaccine. Xinhua's top 10 world news events in 2022 Persistent COVID-19 pandemic profoundly shapes world The persistent COVID-19 pandemic has caused tremendous damage to people's lives and health, had a profound impact on the world economy and people's work and life, and exacerbated supply chain disruptions and labor shortages. Putting people and their lives first, the Chinese government has been optimizing its response measures, and has achieved major positive results in coordinating epidemic prevention and control with socioeconomic development. Countries worldwide should focus o

Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

TOKYO, Japan - Tatsuo Higuchi, president of Otsuka Holdings Co., attends a press conference in Tokyo's Minato Ward on Dec. 2, 2014, on the planned acquisition by its subsidiary Otsuka Pharmaceutical Co. of California-based biopharmaceutical firm Avanir Pharmaceuticals Inc. for $3.54 billion through a tender offer to be followed by a merger. The Japanese nutrition product and drug manufacturer will pay $17 per Avanir share in the takeover bid through its U.S. subsidiary.

Chinese firms popular at Egypt's largest medical expo

STORY: Chinese firms popular at Egypt's largest medical expo DATELINE: June 9, 2022 LENGTH: 0:02:50 LOCATION: Cairo CATEGORY: HEALTH/ECONOMY SHOTLIST: 1 various of the expo 2 SOUNDBITE 1 (Arabic): ESSAM HALIM DEMETRIOS, Egyptian pharmacist 3 various of the expo 4 SOUNDBITE 2 (Arabic): OMAR ABDEL-AZIZ, Director of Egypt's Unified Procurement Authority (UPA) technical bureau STORYLINE: At an exhibition center on the outskirts of the Egyptian capital Cairo, several Chinese pharmaceutical and medical companies have drawn the interests of visitors who were seeking business opportunities in one of the largest medical exhibitions and conferences in Africa. The Africa Health ExCon, which was held from June 5 to 7, featured various products including vaccines, medicines and medical equipment, and host some 350 companies from over 100 countries. Among the firms participating in the event was China's biopharmaceutical company Sinovac, which jointly produces COVID-19 vaccines with Egypt's state-owned vaccine p

EGYPT-CAIRO-AFRICA HEALTH EXCON

EGYPT-CAIRO-AFRICA HEALTH EXCON

(220607) -- CAIRO, June 7, 2022 (Xinhua) -- People visit the booth of China's biopharmaceutical company Sinovac at the Africa Health ExCon in Cairo, Egypt, on June 6, 2022. The Africa Health ExCon, which was held from June 5 to 7, features various products including vaccines, medicines and medical equipment, and hosts some 350 companies from over 100 countries. (Xinhua/Ahmed Gomaa)

China's Sinovac builds vaccine plant in Chile

STORY: China's Sinovac builds vaccine plant in Chile DATELINE: May 13, 2022 LENGTH: 00:00:44 LOCATION: QUILICURA, Chile CATEGORY: SOCIETY/HEALTH SHOTLIST: SOUNDBITE 1 (Chinese): JIANG DEYU, General Manager, Sinovac Holdings (Chile) Ltd. SOUNDBITES 2 (Spanish): FLAVIO SALAZAR, Chilean Minister of Science and Technology STORYLINE: Chinese biopharmaceutical company Sinovac Biotech is building a vaccine plant in Quilicura, Chile. SOUNDBITE 1 (Chinese): JIANG DEYU, General Manager, Sinovac Holdings (Chile) Ltd. "Today's groundbreaking ceremony for the vaccine plant in Chile marks a new beginning." The plant covers an area of over 21,000 square meters and will be dedicated to vaccine filling and production. Once completed, 50 million doses of vaccines could be produced here annually. SOUNDBITES 2 (Spanish): FLAVIO SALAZAR, Chilean Minister of Science and Technology "It's very important for Chile to have an international company like Sinovac to establish a vaccine distribution and filling plant. We believe th

EGYPT-CHINA-VACCINE COLD STORAGE FACILITY-CONSTRUCTION

EGYPT-CHINA-VACCINE COLD STORAGE FACILITY-CONSTRUCTION

(220417) -- CAIRO, April 17, 2022 (Xinhua) -- Chinese Ambassador to Egypt Liao Liqiang addresses the commencement ceremony for a vaccine cold storage facility sponsored by China, in Giza, Egypt, April 14, 2022. The vaccine cold storage facility sponsored by China's Sinovac started construction this week, the Chinese Embassy in Egypt said in a statement on April 16. With the support of the Chinese biopharmaceutical company, the advanced facility will boost Egypt's vaccine storage capacity, Liao Liqiang told the ceremony for the project on Thursday. (Xinhua/Sui Xiankai)